Is there any difference in patterns of use and psychiatric symptom status between injectors and non-injectors of mephedrone?

Máté Kapitány-Fövény, Barbara Mervõ, Máté Kertész, Ornella Corazza, J. Farkas, Gyöngyi Kökönyei, R. Urbán, Z. Demetrovics

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective In recent years, increasing intravenous mephedrone use was reported in several countries. The aim of this study was to describe the characteristics of such a form of mephedrone use, while identifying the differences between injectors and non-injectors in patterns of mephedrone use and psychiatric symptom status. Methods One hundred and forty-five mephedrone users were surveyed on patterns of mephedrone use using a structured questionnaire as well as the Brief Symptom Inventory. Results Majority of users received mephedrone from acquaintances and used it in discos/parties settings regarding both first and current mephedrone use. Intranasal use was the most typical route of administration (84.4%). Injectors (11%) used the drug more frequently and in higher dosages. This group included a greater proportion of opiate users (37.5%) and showed more diffuse psychiatric symptoms. Regarding the predictors of being an injector, heroin use showed the highest odds ratio. Conclusions Intravenous mephedrone use is associated with a higher risk of harmful drug use, elevated psychiatric symptom profile and increased possibility of mephedrone being considered as an addictive substance. These findings might be important in efficient treatment planning.

Original languageEnglish
Pages (from-to)233-243
Number of pages11
JournalHuman Psychopharmacology
Volume30
Issue number4
DOIs
Publication statusPublished - Jul 1 2015

Fingerprint

Psychiatry
Opiate Alkaloids
mephedrone
Heroin
Pharmaceutical Preparations
Odds Ratio
Equipment and Supplies

Keywords

  • 4-methylmethcathinone
  • injecting
  • mephedrone
  • patterns of use
  • psychiatric symptoms

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Neurology
  • Pharmacology (medical)

Cite this

Is there any difference in patterns of use and psychiatric symptom status between injectors and non-injectors of mephedrone? / Kapitány-Fövény, Máté; Mervõ, Barbara; Kertész, Máté; Corazza, Ornella; Farkas, J.; Kökönyei, Gyöngyi; Urbán, R.; Demetrovics, Z.

In: Human Psychopharmacology, Vol. 30, No. 4, 01.07.2015, p. 233-243.

Research output: Contribution to journalArticle

Kapitány-Fövény, Máté ; Mervõ, Barbara ; Kertész, Máté ; Corazza, Ornella ; Farkas, J. ; Kökönyei, Gyöngyi ; Urbán, R. ; Demetrovics, Z. / Is there any difference in patterns of use and psychiatric symptom status between injectors and non-injectors of mephedrone?. In: Human Psychopharmacology. 2015 ; Vol. 30, No. 4. pp. 233-243.
@article{6c3586c978bb49cf86b303459697bd3c,
title = "Is there any difference in patterns of use and psychiatric symptom status between injectors and non-injectors of mephedrone?",
abstract = "Objective In recent years, increasing intravenous mephedrone use was reported in several countries. The aim of this study was to describe the characteristics of such a form of mephedrone use, while identifying the differences between injectors and non-injectors in patterns of mephedrone use and psychiatric symptom status. Methods One hundred and forty-five mephedrone users were surveyed on patterns of mephedrone use using a structured questionnaire as well as the Brief Symptom Inventory. Results Majority of users received mephedrone from acquaintances and used it in discos/parties settings regarding both first and current mephedrone use. Intranasal use was the most typical route of administration (84.4{\%}). Injectors (11{\%}) used the drug more frequently and in higher dosages. This group included a greater proportion of opiate users (37.5{\%}) and showed more diffuse psychiatric symptoms. Regarding the predictors of being an injector, heroin use showed the highest odds ratio. Conclusions Intravenous mephedrone use is associated with a higher risk of harmful drug use, elevated psychiatric symptom profile and increased possibility of mephedrone being considered as an addictive substance. These findings might be important in efficient treatment planning.",
keywords = "4-methylmethcathinone, injecting, mephedrone, patterns of use, psychiatric symptoms",
author = "M{\'a}t{\'e} Kapit{\'a}ny-F{\"o}v{\'e}ny and Barbara Merv{\~o} and M{\'a}t{\'e} Kert{\'e}sz and Ornella Corazza and J. Farkas and Gy{\"o}ngyi K{\"o}k{\"o}nyei and R. Urb{\'a}n and Z. Demetrovics",
year = "2015",
month = "7",
day = "1",
doi = "10.1002/hup.2490",
language = "English",
volume = "30",
pages = "233--243",
journal = "Human Psychopharmacology",
issn = "0885-6222",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Is there any difference in patterns of use and psychiatric symptom status between injectors and non-injectors of mephedrone?

AU - Kapitány-Fövény, Máté

AU - Mervõ, Barbara

AU - Kertész, Máté

AU - Corazza, Ornella

AU - Farkas, J.

AU - Kökönyei, Gyöngyi

AU - Urbán, R.

AU - Demetrovics, Z.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Objective In recent years, increasing intravenous mephedrone use was reported in several countries. The aim of this study was to describe the characteristics of such a form of mephedrone use, while identifying the differences between injectors and non-injectors in patterns of mephedrone use and psychiatric symptom status. Methods One hundred and forty-five mephedrone users were surveyed on patterns of mephedrone use using a structured questionnaire as well as the Brief Symptom Inventory. Results Majority of users received mephedrone from acquaintances and used it in discos/parties settings regarding both first and current mephedrone use. Intranasal use was the most typical route of administration (84.4%). Injectors (11%) used the drug more frequently and in higher dosages. This group included a greater proportion of opiate users (37.5%) and showed more diffuse psychiatric symptoms. Regarding the predictors of being an injector, heroin use showed the highest odds ratio. Conclusions Intravenous mephedrone use is associated with a higher risk of harmful drug use, elevated psychiatric symptom profile and increased possibility of mephedrone being considered as an addictive substance. These findings might be important in efficient treatment planning.

AB - Objective In recent years, increasing intravenous mephedrone use was reported in several countries. The aim of this study was to describe the characteristics of such a form of mephedrone use, while identifying the differences between injectors and non-injectors in patterns of mephedrone use and psychiatric symptom status. Methods One hundred and forty-five mephedrone users were surveyed on patterns of mephedrone use using a structured questionnaire as well as the Brief Symptom Inventory. Results Majority of users received mephedrone from acquaintances and used it in discos/parties settings regarding both first and current mephedrone use. Intranasal use was the most typical route of administration (84.4%). Injectors (11%) used the drug more frequently and in higher dosages. This group included a greater proportion of opiate users (37.5%) and showed more diffuse psychiatric symptoms. Regarding the predictors of being an injector, heroin use showed the highest odds ratio. Conclusions Intravenous mephedrone use is associated with a higher risk of harmful drug use, elevated psychiatric symptom profile and increased possibility of mephedrone being considered as an addictive substance. These findings might be important in efficient treatment planning.

KW - 4-methylmethcathinone

KW - injecting

KW - mephedrone

KW - patterns of use

KW - psychiatric symptoms

UR - http://www.scopus.com/inward/record.url?scp=84938065052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938065052&partnerID=8YFLogxK

U2 - 10.1002/hup.2490

DO - 10.1002/hup.2490

M3 - Article

VL - 30

SP - 233

EP - 243

JO - Human Psychopharmacology

JF - Human Psychopharmacology

SN - 0885-6222

IS - 4

ER -